Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: A comparative pilot study

Journal of Nephrology

Volumn 26, Issue 1, 2013, Pages 152-157

  Daroux, Maïté ^a,b   Shenouda, Milhad ^a   Bacri, Jean Louis ^c   Lemaitre, Vincent ^c   Vanhille, Philippe ^c   Bataille, Pierre ^a  

^a Department of Nephrology Duchenne Hospital   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CENTRE HOSPITALIER DE VALENCIENNES   (France)

Author keywords

Cholecalciferol; Ergocalciferol; Hemodialysis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN; VITAMIN D;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; PILOT STUDY; PROSPECTIVE STUDY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; AGED; BLOOD; CHI SQUARE DISTRIBUTION; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; MIDDLE AGED; NONPARAMETRIC TEST; RENAL REPLACEMENT THERAPY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHOLECALCIFEROL; ERGOCALCIFEROLS; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; STATISTICS, NONPARAMETRIC; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84877087672     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000123     Document Type: Article

References (32)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357 (3):266-281.
2. Drechsler C, Verduijn M, Pilz S, et al; NECOSAD Study Group. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. 2011;26(3):1024-1032.
3. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008;4(8):404-412.
4. Messa P, Alfieri C, Rastaldi MP. Recent insights into vitamin D and its receptor. J Nephrol. 2011;24(Suppl 18):S30-S37.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4)(Suppl 3):S1-S201.
6. Ghazali A, Fardellone P, Pruna A, et al. Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int. 1999; 55(6):2169-2177.
7. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72(8):1004-1013.
8. Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75(1):88-95.
9. Barreto DV, Barreto FC, Liabeuf S, et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1128-1135.
10. Ishimura E, Nishizawa Y, Inaba M, et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999;55(3):1019-1027.
11. Blair D, Byham-Gray L, Lewis E, McCaffrey S. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr. 2008;18(4):375-382.
12. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int. 2005;25(4):362-366.
13. Jacob AI, Sallman A, Santiz Z, Hollis BW. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr. 1984;114(7):1313-1319.
14. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84(4): 694-697.
15. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89(11):5387-5391.
16. Kooienga L, Fried L, Scragg R, Kendrick J, Smits G, Chonchol M. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009;53(3):408-416.
17. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68(4):854-858.
18. Romagnoli E, Mascia ML, Cipriani C, et al. Short and longterm variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93(8):3015-3020.
19. Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW. Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease. J Nephrol. 2009;22(1):75-82.
20. Matias PJ, Jorge C, Ferreira C, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5(5):905-911.
21. Qunibi WY, Abdellatif A, Sankar S, et al. Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate? Clin Nephrol. 2010;73(4):276-285.
22. Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007;50(1):59-68.
23. DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton). 2006;11(6):555-559.
24. Zisman AL, Hristova M, Ho LT, Sprague SM. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol. 2007;27(1):36-43.
25. Courbebaisse M, Thervet E, Souberbielle JC, et al. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 2009;75(6):646-651.
26. Tokmak F, Quack I, Schieren G, et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant. 2008;23(12):4016-4020.
27. Chandra P, Binongo JN, Ziegler TR, et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract. 2008;14(1):10-17.
28. Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant. 2009;24(12):3799-3805.
29. Mehrotra R, Kermah D, Budoff M, et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3(4):1144-1151.
30. Michaud J, Naud J, Ouimet D, et al. Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol. 2010;21(9): 1488-1497.
31. Mistretta VI, Delanaye P, Chapelle JP, Souberbielle JC, Cavalier E. [Vitamin D2 or vitamin D3?] [article in French]. Rev Med Interne. 2008;29(10):815-820.
32. Mazzaferro S, Brancaccio D, Messa P, et al; FARO Study Group. Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey. J Nephrol. 2011;24(2): 225-235.